NOVARTIS AG - Ordinary Shares (NVS)

CUSIP: 66987V109

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Ordinary Shares
Shares outstanding
2,181,288,547
Total 13F shares
226,235,539
Share change
-11,485,585
Total reported value
$19,668,553,299
Put/Call ratio
65%
Price per share
$86.96
Number of holders
1,114
Value change
-$999,534,657
Number of buys
401
Number of sells
531

Quarterly Holders Quick Answers

What is CUSIP 66987V109?
CUSIP 66987V109 identifies NVS - NOVARTIS AG - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q3 2020

As of 30 Sep 2020, NOVARTIS AG - Ordinary Shares (NVS) was held by 1,114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 226,235,539 shares. The largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, Dodge & Cox, LOOMIS SAYLES & CO L P, Fisher Asset Management, LLC, Mawer Investment Management Ltd., FRANKLIN RESOURCES INC, BANK OF AMERICA CORP /DE/, Aristotle Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and UBS Group AG. This page lists 1,114 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.